Vericel (VCEL) Retained Earnings (2010 - 2026)
Vericel's (VCEL) quarterly Retained Earnings came in at -$382.6 million in Q1 2026, up 5.31% year-on-year from -$363.3 million in Q1 2025, and down 139227.27% quarter-over-quarter from $275000.0 in Q4 2025.
Vericel (VCEL) Retained Earnings (2010 - 2026) Analysis & Trends
Vericel has disclosed Retained Earnings across 17 years of filings, most recently posting -$382.6 million for Q1 2026.
- Retained Earnings for Q1 2026 came in at -$382.6 million, up 5.31% year-over-year; the trailing twelve-month figure through Mar 2026 was -$382.6 million (up 5.31% YoY), and the FY2025 annual result was $275000.0, up 100.07% from the prior year.
- Retained Earnings came in at -$382.6 million for Q1 2026 at Vericel, down from $275000.0 in the prior quarter.
- In the past five years, Retained Earnings ranged from a high of $275000.0 in Q4 2025 to a low of -$416.2 million in Q3 2023.
- The 5-year median for Retained Earnings is -$392.8 million (2024), against an average of -$260.7 million.
- Across the five-year window, Retained Earnings sank 1764756.52% in 2022 and jumped 167.03% in 2025, its largest moves.
- Vericel's Retained Earnings stood at -$978000.0 in 2022, then surged by 89.78% to -$100000.0 in 2023, then plunged by 392715.0% to -$392.8 million in 2024, then jumped by 100.07% to $275000.0 in 2025, then slumped by 139227.27% to -$382.6 million in 2026.
- The last three Retained Earnings figures came in at -$382.6 million (Q1 2026), $275000.0 (Q4 2025), and $258000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | -153.89 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -211.85 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 1.00 Bn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 130.89 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -279.00 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -1.88 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 14.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -838.07 Mn |
| 10 | Vericel | 2.04 Bn | 1.90 Bn | 49.27 Mn | -382.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -382.60 Mn |
| Dec 31, 2025 | 275,000.00 |
| Sep 30, 2025 | 258,000.00 |
| Jun 30, 2025 | 183,000.00 |
| Mar 31, 2025 | -404.06 Mn |
| Dec 31, 2024 | -392.82 Mn |
| Sep 30, 2024 | -412.60 Mn |
| Jun 30, 2024 | -273,000.00 |
| Mar 31, 2024 | -407.04 Mn |
| Dec 31, 2023 | -100,000.00 |
| Sep 30, 2023 | -416.20 Mn |
| Jun 30, 2023 | -412.51 Mn |
| Mar 31, 2023 | -407.50 Mn |
| Dec 31, 2022 | -978,000.00 |
| Sep 30, 2022 | -405.92 Mn |
| Jun 30, 2022 | -399.30 Mn |
| Mar 31, 2022 | -390.38 Mn |
| Dec 31, 2021 | -154,000.00 |
| Sep 30, 2021 | -23,000.00 |
| Jun 30, 2021 | -382.89 Mn |